You are on page 1of 3

IBM® Explorys®

Therapeutic
Datasets Delivered
Evidence of real-world treatment value is essential to successful Key benefits
commercialization. IBM Explorys Therapeutic Datasets Delivered
provides deidentified real-world data for researchers to translate Longitudinality
into actionable insights about topics like the patient journey, provider IDN/CIN-based sourcing model
prescribing patterns, disease progression, procedure volumes, facilitates tracking specific patients
and the overall delivery of care throughout the United States. over time to give a more holistic
view of health behaviors

Attributes of full data set Volume & Depth


Rich clinical detail from Explorys’
Health System Partners (IDNs & CINs) >40 >53 million unique patient lives
Acute Care Facilities >400 facilitates robust analyses
Providers & Physicians >400,000
Flexibility
Visits 2.0 billion 49.3 million
Data is housed in client’s US-based
ambulatory visit records patients with
data center environment and can
ambulatory visits
be analyzed using client’s choice
4.4 million 1.3 million of analytic tools
emergency visit records patients with
emergency visits Reputation
46.2 million 9.9 million Explorys data has been used
inpatient visit records patients with in thousands of studies over
inpatient visits the course of the past 11 years
Medications 1.7 billion 30.9 million
medication records patients with
medication
Procedures 6.0 billion 43.8 million
procedure records patients with
procedures
Observations 15.0 billion 36.2 million
observation records patients with
observations

Source: IBM Explorys Data, August 2020

Geographic distribution of patients


Selected use cases © Copyright IBM Corporation 2020.

IBM Corporation,
Forecasting treatment Identifying treatment Watson Health, 75 Binney St,
Cambridge, MA 02142
non-adherence response patterns
Developed predictive model to Identified cohort of patients who Produced in the United States of America,
August 2020.
reliably forecast non-adherence do not respond to 1st & 2nd line
to medications in behavioral diabetes therapies but aver very IBM, the IBM logo, ibm.com,are trademarks
of International Business Machines Corp.,
health patients responsive to 3rd line therapy registered in many jurisdictions worldwide. Other
product and service names might be trademarks
of IBM or other companies. A current list of IBM
Making data-driven Projecting impact of attributes trademarks is available on the web at “Copyright
treatment recommendations on risk of critical condition and trademark information” at www.ibm.com/legal/
copytrade.shtml. This document is current as of the
Created predictive model to Constructed prognostic model to initial date of publication and may be changed by
recommend specific drug project which COVID-19 patient IBM at any time. Not all offerings are available in
every country in which IBM operates.
regimens to treat HIV patients types are at risk of critical state
based on genetic makeup of within a month of diagnosis The performance data and client examples cited
are presented for illustrative purposes only. Actual
their viral load performance results may vary depending on
specific configurations and operating conditions.
THE INFORMATION IN THIS DOCUMENT IS
PROVIDED “AS IS” WITHOUT ANY WARRANTY,
About IBM Watson Health EXPRESS OR IMPLIED, INCLUDING WITHOUT
ANY WARRANTIESOF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND
IBM Watson Health is a data, analytics, and technology partner for the ANY WARRANTY OR CONDITION OF NON-
INFRINGEMENT. IBM products are warranted
health industry. Supported by the innovation of IBM and intelligence of according to the terms and conditions of the
Watson, we are committed to helping build smarter health ecosystems. agreements under which they are provided.

Through the combination of our deep industry expertise in health, data


and analytics, actionable insights, and reputation for security and
trust, Watson Health is working together with its clients and partners
to help them achieve simpler processes, better care insights, faster
breakthroughs, and improved experiences for people around the world.
Learn more at ibm.com/watson/health.

For more information

To learn more about IBM Explorys EHR Database offerings for Life
Sciences, please contact your IBM representative or visit the following
website: www.ibm.com/watson/health/explorys/healthcare-analytics

You might also like